500 West 5th Street
Austin, TX 78701
512 900 4690
Full-time employees: 105
|Dr. Taylor H. Schreiber M.D., Ph.D.||Co-Founder, CEO & Director||783.75k||N/A||1980|
|Dr. Abhinav A. Shukla Ph.D.||Chief Technical Officer||567.4k||N/A||1973|
|Dr. Arundathy Nirmalini Pandite M.B.A., M.D.||Chief Medical Officer||678.76k||N/A||1959|
|Mr. Andrew R. Neill M.B.A.||Chief Financial Officer||N/A||N/A||1986|
|Mr. Conor Richardson CPA||VP of Investor Relations||N/A||N/A||N/A|
|Dr. Stephen Stout J.D., Ph.D.||Gen. Counsel, Corp. Sec. and Chief Ethics & Compliance Officer||N/A||N/A||N/A|
|Ms. Casi DeYoung||Chief Bus. Officer||N/A||N/A||1971|
|Dr. Thomas Lampkin Pharm.D.||Sr. VP of Regulatory Affairs||N/A||N/A||N/A|
|Mr. George Fromm Ph.D.||Chief Scientific Officer of ARC Platform||N/A||N/A||N/A|
|Mr. Suresh de Silva Ph.D.||Chief Scientific Officer of GADLEN Platform||N/A||N/A||N/A|
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. The company was incorporated in 2016 and is headquartered in Austin, Texas.
Shattuck Labs, Inc.’s ISS governance QualityScore as of 1 June 2023 is 6. The pillar scores are Audit: 3; Board: 6; Shareholder rights: 8; Compensation: 7.